No one has been doing the happy dance to the tune that Big Pharma has been singing the last couple of years. So now, it has decided to sing another tune.

We're done being on the defensive, goes the chorus of the new song, composed by Steve Ubl, president and CEO of the Pharmaceutical Researcher and Manufacturers Association (PharMA). Instead, we'll let our patients sing our praises.

That, at least, is the gist of the message Ubl and his messaging team have come up with. According to The Hill, Ubl thinks Washington decision makers should know the truth about costly drugs — that they save lives and control diseases that were deadly just a few years ago. So Ubl is going to send a battalion of researchers and patients to Congress to lobby on behalf of the very drugs lawmakers say are gouging the public and insurance providers.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.